Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Risky behaviour: Most Americans unaware of alcohol–cancer link
Despite decades of evidence showing alcohol as a known carcinogen, the majority of U.S. adults…
Should H. pylori be treated in children to prevent gastric cancer?
A new JAMA Pediatrics Viewpoint argues that Helicobacter pylori infection in children should be routinely…
Consistency is the key: regular moderate exercise linked to lower digestive system cancer risk and mortality
Digestive system cancers (DSCs)—encompassing cancers of the digestive tract (mouth, throat, oesophagus, stomach, small intestine,…
The OJC 64: Going Dutch with Pancreatic Cancer and DRUP
In today’s episode Craig talks us through a Dutch study on Neoadjuvant Chemoradiotherapy in pancreatic cancer. Hans also goes Dutch…
Medical experts launch Australia’s first lung cancer molecular testing best practice recommendations ahead of National Lung Cancer Screening Program
- Study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer
- European Commission approves lazertinib in combination with amivantamab for the first-line treatment of patients with EGFR-mutated advanced NSCLC
- New dual stem cell therapy developed to treat brain metastasis in patients with non-small cell lung cancer
Cancer evolution is mathematical – how random processes and epigenetics can explain why tumor cells shape-shift, metastasize and resist treatments
Andrew Feinberg, Johns Hopkins University Cancer is often seen as a disease that arises from genetic mutations causing cells to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.